FundedIQ
Biotechnology

Krystal Biotech: Funding, Investors & Team (Aug 2026)

Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that provide significant clinical benefit for patients suffering from rare debilitating disorders.

www.krystalbio.com Pittsburgh, United States 101-250 employees
Total raised
$160M
Rounds
1
Latest
Undisclosed round
May 2023

Krystal Biotech has raised $160M across 1 funding round on record, the most recent an undisclosed round of $160M announced in May 2023.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Krystal Biotech Company Profile and Key Stats

Total funding raised
$160M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$160M in May 2023
Employees
101-250
reported band
Headquarters
Pittsburgh, United States

Latest funding round on record: May 2023.

Krystal Biotech Funding Rounds

Date
Round
Amount
Undisclosed round
$160M

Krystal Biotech Founders and Leadership Team

Name
Role
Contact
Suma Krishnan
Founder
Locked

Contact details for the Krystal Biotech team: 1 of 1 has an email address on file.

Start 14-day free trial →

Krystal Biotech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Krystal Biotech's latest round of $160M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Krystal Biotech in Biotechnology and Pittsburgh

Companies Similar to Krystal Biotech

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Krystal Biotech Funding FAQs

What does Krystal Biotech do?

Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that provide significant clinical benefit for patients suffering from rare debilitating disorders.

How much funding has Krystal Biotech raised?

Krystal Biotech has raised $160M across 1 round on record. The most recent is an undisclosed round of $160M announced in May 2023.

When did Krystal Biotech last raise funding?

Krystal Biotech's most recent funding round on record is an undisclosed round of $160M, announced in May 2023.

Who founded Krystal Biotech?

FundedIQ lists Suma Krishnan (Founder) at Krystal Biotech.

Where is Krystal Biotech headquartered?

Krystal Biotech is based in Pittsburgh, Pennsylvania, United States.

How many employees does Krystal Biotech have?

Krystal Biotech is in the 101-250 employee band.

How does Krystal Biotech's funding compare to other Biotechnology startups?

Krystal Biotech's latest round of $160M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Krystal Biotech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Krystal Biotech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.